Statements in antidepressant advertisements advancing general or comparative efficacy in depression treatment, or professing monoamine theories.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://figshare.com/articles/dataset/_Statements_in_antidepressant_advertisements_advancing_general_or_comparative_efficacy_in_depression_treatment_or_professing_monoamine_theories_/695538
下载链接
链接失效反馈官方服务：
资源简介：
1Number of ads containing claims or theories/number of ads found in breach by the IGM/NBL for this, e.g. 16 unique ads professed general efficacy claims; zero were found to be in violation for this.
2Percentage of ads containing claims or theories of total, e.g. 12.9% of 124 unique advertisements professed general efficacy claims.
3Percentage of ads found in breach by the IGM/NBL of ads containing claims or theories, e.g. 16 unique ads professed general efficacy claims; zero percent were found to be in violation for this.
4Italicized statements were found to breach the code by the IGM/NBL. Case number in the IGM/NBL database is indicated.
创建时间：
2013-05-01
